<DOC>
	<DOCNO>NCT02066623</DOCNO>
	<brief_summary>The German-Austrian ABSORB Register shall provide analysis acute long-term safety well therapy outcomes ABSORB ( trade mark ) bioresorbable vascular scaffold system patient suffer coronary artery disease .</brief_summary>
	<brief_title>Observational Study Evaluate Short Long-term Safety ABSORB Scaffold</brief_title>
	<detailed_description>The register collect prospective data regard quality care therapy concept include specifically follow objective : - Documentation consecutive patient treat ABSORB biore-sorbable vascular scaffold system clinical real-world condition - Documentation indication , procedural result , short long-term outcome - Documentation technical performance ABSORB implant procedure - Collection safety data , particular documentation hospital mortality , major non-fatal complication ( especially myocardial infarction , Re-PCI ( percutaneous coronary intervention ) CABG ( coronary artery bypass grafting ) , stroke , thrombosis ) - Documentation long-term patient safety mark mortality major non-fatal complication ( especially myocardial infarction , Re-PCI CABG , stroke , thrombosis ) 30 day , 6 month , 2 year 5 year - Gathering health economics data ( capture direct cost , especially view change medication outpatient/inpatient hospital service , indirect cost ) pre post ABSORB implant - Gathering data quality life pre post ABSORB implant document individual QoL dimension well QALY ( quality adjust life year ) data</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>ABSORB implant schedule Age 18+ Patients give consent keep schedule followup Signed informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>coronary artery stenosis , vascular scaffold , ABSORB</keyword>
</DOC>